The development of a screening tool to evaluate gross motor function in HIV-infected infants
- 14 June 2011
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 23 (12) , 1619-1625
Abstract
Neurodevelopmental delay or HIV encephalopathy is a stage four disease indicator for paediatric HIV/AIDS according to the World Health Organisation (WHO), and may be used as a criterion for initiation of highly active antiretroviral therapy (HAART). To date, the only means of prevention of this condition is early initiation of HAART. Studies which have been carried out in South African clinics have revealed the high prevalence of this condition. In developing countries, commencement of HAART is based on declining virologic and immunologic status, as standardised neurodevelopmental assessment tools are not widely available. A standardised developmental screening tool which is suitable for use in a developing country is therefore necessary in order to screen for neurodevelopmental delay to allow for further assessment and referral to rehabilitation services, as well as providing an additional assessment criterion for initiation of HAART. The infant gross motor screening test (IGMST) was developed for this purpose. The standardisation sample of the IGMST consisted of 112 HIV-infected infants between six and 18 months of age. Item selection for the IGMST was based on the Gross Motor scale of the Bayley Scales of Infant Development (BSID)-III. Content validity was assessed by a panel of experts using a nominal group technique (NGT; agreement >80%). Concurrent validity (n=60) of the IGMST was carried out against the BSID-III, and agreement was excellent (K=0.85). The diagnostic properties of the IGMST were evaluated and revealed: sensitivity 97.4%, specificity 85.7%, positive predictive value (PPV) 92.7%, and negative predictive value (NPV) 94.7%. Reliability testing (n=30) revealed inter-rater reliability as: r=1, test-retest reliability: r=0.98 and intra-rater reliability: r=0.98. The results indicate that the statistical properties of the IGMST are excellent, and the tool is suitable for use within the paediatric HIV setting.Keywords
This publication has 30 references indexed in Scilit:
- The effect of a basic home stimulation programme on the development of young children infected with HIVDevelopmental Medicine & Child Neurology, 2010
- Neurodevelopmental Trajectory of HIV-Infected Children Accessing Care in Kinshasa, Democratic Republic of CongoJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- The prevalence of motor delay among HIV infected children living in Cape Town, South AfricaInternational Journal of Rehabilitation Research, 2009
- Neurodevelopmental delay in children infected with human immunodeficiency virus in Soweto, South AfricaVulnerable Children and Youth Studies, 2009
- Impact of the HIV/AIDS Epidemic on the Neurodevelopment of Preschool-Aged Children in Kinshasa, Democratic Republic of the CongoPediatrics, 2008
- Second assessment of NeuroAIDS in AfricaJournal of NeuroVirology, 2008
- Can Western developmental screening tools be modified for use in a rural Malawian setting?Archives of Disease in Childhood, 2008
- Neurodevelopmental outcomes in children with HIV infection under 3 years of ageDevelopmental Medicine & Child Neurology, 2006
- Predictive utility of the Bayley Infant Neurodevelopmental Screener (BINS) risk status classifications: clinical interpretation and applicationDevelopmental Medicine & Child Neurology, 2000
- Developmental screening: Rationale, methods, and applicationInfants & Young Children, 1991